Supporting today's women with diabetes requires nurse and other care providers to understand the basics and the possibilities of CSII. As the number of people with preexisting diabeter increases and technology continues to improve. There is need for randomzed controlled trials to determine best practices for women during pregnandy. labor and delirery. and the postpartum period,as well as for CSII use in the years follwing menopause.
Althongh CSII was designed for use in people with type I diabetar, the use of insulin pumps for managing type2 diabetes is receiving more attention. As patients with type2 diabetes fase declining beta cell function.most will require insulin therapy to provide glycemic control (Holmen et al. 2009). Recent studies have not found CSII to be clinically superior to insulin injection; however, overall preference for CSII was reported by study participant due to convenience, tlexbility and ease of use (Bode,2010). Research and develment of simpler insulin pumps and protocols for the popukation of patients with type2 diabeter is in progress.
Work is ongoing with efforts for a closed-loop system or "artificial pancreas" This system would consist of continuse glucose monitoring,an insulin pump and a controlling device this sensor-augmented - pump would automantically suspend basal insulin response to low glucose readinf (Choudhary et al,2011)